A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Following prescribed medication regimens is essential for the effective treatment of any medical condition. Unfortunately, patients often fail to follow recommendations, and treatment non-compliance represents a widespread, often underestimated problem, placing tremendous burden on the healthcare system. Compliance in Alzheimer's disease (AD), a chronic neurodegenerative disease typically afflicting older adults, is especially challenging. SCOPE: To review factors contributing to poor treatment compliance in AD, considering the prominent role care givers often play in treatment management; and acknowledging strategic approaches, particularly modern transdermal patches, to improve compliance in this particularly susceptible population. Articles were identified by searching MEDLINE in November 2006 (search limits: 1987-2007) using the terms: compliance; Alzheimer's; treatment; and transdermal. Additional resources included bibliographies of identified articles. FINDINGS: Strategic approaches to improving treatment compliance include: simplifying treatment regimens, using reminder packaging, and developing more patient- or caregiver-friendly modes of administration. To date, AD therapies have been administered orally. However, recent developments in alternative modes of drug delivery, such as transdermal patches, may offer effective, well-tolerated treatment options with the potential to enhance compliance. A patch containing rivastigmine (Exelon), an established cholinesterase inhibitor, has been developed and demonstrated to have good efficacy and tolerability in patients with AD. In addition, initial caregiver experience suggests preference for the patch over oral administration. CONCLUSION: Transdermal patches may be an effective way to optimize treatment compliance for AD, as well as an increasing number of other chronic conditions that typically afflict the older population, offering the possibility of more sustained clinical benefits.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Fratiglioni, L., Grut, M., Forsell, Y., Viitanen, M., Grafström, M., Holmen, K., Ericsson, K., Bäckman, L., Ahlbom, A., & Winblad, B. (1991) · Neurology · doi:10.1212/wnl.41.12.1886 · Cited by 525
Assessing Medication Adherence in the Elderly: Which Tools to Use in Clinical Practice?
MacLaughlin, E. J., Raehl, C. L., Treadway, A. K., Sterling, T. L., Zoller, D. P., & Bond, C. A. (2005) · Drugs & Aging · doi:10.2165/00002512-200522030-00005 · Cited by 363
Drug therapy in the elderly: what doctors believe and patients actually do
Barat, I., Andreasen, F., & Damsgaard, E. M. S. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01401.x · Cited by 334
The Costs of Caring: Impact of Dementia on Family Caregivers
Connell, C. M., Janevic, M. R., & Gallant, M. P. (2001) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870101400403 · Cited by 241
van Eijken, M., Tsang, S., Wensing, M., de Smet, P. A. G. M., & Grol, R. P. T. M. (2003) · Drugs & Aging · doi:10.2165/00002512-200320030-00006 · Cited by 184
Medication compliance and older people: a review of the literature
Ryan, A. A. (1999) · International Journal of Nursing Studies · doi:10.1016/s0020-7489(99)00003-6 · Cited by 113
Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors
Gillette-Guyonnet, S., Andrieu, S., Cortes, F., Nourhashemi, F., Cantet, C., Ousset, P.-J., Reynish, E., Grandjean, H., & Vellas, B. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.5.516 · Cited by 41
Cited by
Simoni, E., Daniele, S., Bottegoni, G., Pizzirani, D., Trincavelli, M. L., Goldoni, L., Tarozzo, G., Reggiani, A., Martini, C., Piomelli, D., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3009458 · Cited by 163
Caregiver Burden and Psychoeducational Interventions in Alzheimer’s Disease: A Review
Beinart, N., Weinman, J., Wade, D., & Brady, R. (2012) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000345777 · Cited by 124
Predictors of adherence among Alzheimer's disease patients receiving oral therapy
Borah, B., Sacco, P., & Zarotsky, V. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.493788 · Cited by 67
Olde Rikkert, M. G. M., Verhey, F. R., Blesa, R., von Arnim, C. A. F., Bongers, A., Harrison, J., Sijben, J., Scarpini, E., Vandewoude, M. F. J., Vellas, B., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141305 · Cited by 61
“Good compliance to an intervention is of particular importance in clinical practice, where adherence to AD therapies is often poor and represents a major problem [28].”
Background
Metadata
- Authors
- Small, G., & Dubois, B.
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa Healthcare
- Published
- 2007-09-21
- Volume
- 23
- Issue
- 11
- Pages
- 2705-2713
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W2106585418
- Cited by
- 150
- References
- 9
- FWCI
- 6.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch. https://app.cochat.ai/papers/10.1185/030079907x233403
- The paper
- Small, G., & Dubois, B. (2007). A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch. Current Medical Research and Opinion. https://doi.org/10.1185/030079907x233403
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.